SallenSEEZinbergNEFreiE. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med1975; 293: 795–7.
2.
LucasVSLazloJ. Delta-9-tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. JAMA1980; 243: 1241–3.
3.
ChangAEShilingDJStillmanRC. Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. Ann Intern Med1979; 91: 819–24.
4.
FrytakSMoertelCGO'FallonJR. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. Ann Intern Med1979; 91: 825–30.
5.
OrrLEMcKernanJFBloomeB. Antiemetic effect of tetrahydrocannabinol. Arch Intern Med1980; 140: 1431–3.
6.
SallenSECroninCZeelenM. Antiemetics in patients receiving chemotherapy for cancer. N Engl J Med1980; 302: 135–8.
7.
UngerleiderJTAndrysiakTFairbanksL. Cannabis and cancer chemotherapy, a comparison of oral delta-9-THC and prochlorperazine. Cancer1981; 50: 636–45.
8.
EkertHWatersKDJurkIH. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. Med J Aust1978; 2: 657–9.
9.
CollsBMFerryDGGrayAJ. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy. NZ Med J1980; 91: 449–51.
10.
NeidhartJAGagenMMWilsonHE. Comparative trial of the antiemetic effects of THC and haloperidol. J Clin Pharmacol1981; 21 (suppl):38–42.
11.
KleinmanSWeitzmanSACassemN. Double-blind trial of delta-9-tetrahydrocannabinol (THC) versus placebo as an adjunct to prochlorperazine for chemotherapy-induced vomiting. Curr Ther Res1983; 33: 1014–7.
12.
BartlettJGGorbachSL. Treatment of aspiration pneumonia and primary lung abscess: Penicillin G vs. clindamycin. JAMA1975; 234: 935–7.
13.
BartlettJGGorbachSL. Penicillin or clindamycin for primary lung abscess. Ann Intern Med1983; 98: 546–8.
14.
RohatgiKPKuzmowychTV. Therapy of anaerobic infections. Hosp Form1981; 16: 1296–1309.
15.
DonowitzGL. Empiric treatment for pneumonia. Rev Infect Dis1983; 5: 540–54.
16.
DhwanVKThadepalliH. Clindamycin: A review of fifteen years of experience. Rev Infect Dis1982; 4: 1133–53.
17.
FinegoldSM. Lung abscess. In: MandellGLDouglasRGBennettJE, eds. Principles and practice of infectious diseases. New York: John Wiley & Sons, 1985: 407–12.
18.
LevisonMEManguraCTLarberB. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med1983; 98: 466–71.
BawdonRECraneLRPalchauduriS. Antibiotic resistance in anaerobic bacteria: Molecular biology and clinical aspects. Rev Infect Dis1982; 4: 1075–95.
21.
EdsonRSRosenblattJELeeDTMcVeyEA. Recent experience with antimicrobial susceptibility of anaerobic bacteria: Increasing resistance to penicillin. Mayo Clin Proc1982; 57: 737–41.
